Baylor Scott & White All Saints Medical Center
Fort Worth, Texas, 76104, United States
NCT Number: NCT06997016
The goal of this interventional study is to learn if an Enhanced Recovery After Surgery (ERAS) protocol works to reduce the need for narcotic pain medications in live donor kidney transplant recipients. The main questions it aims to answer are:
Does the ERAS protocol lower the amount of opioid narcotic medication needed to manage post-surgery pain? Does the ERAS protocol help lower pain scores after surgery? Researchers will compare the ERAS protocol to previous patients where the ERAS protocol was not used to see if the ERAS protocol works to reduce post-surgery pain.
Participants will be asked to:
* Drink a pre-surgery carbohydrate drink two hours before your surgery. * Take a pre-surgery dose of Tylenol by mouth. * Take a pre-surgery dose of Gabapentin by mouth. * The surgeon will administer a local numbing medication at the surgery site by injection during the surgery. * Begin walking with assistance about 12 hours after your surgery. * Allow the research staff to collect data about your kidney function. This data will be collected on your postoperative clinic visits, which generally occur about twice weekly for one month. This information will determine your kidney health, need for hospitalization, and side effects that may occur.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 4
Fort Worth, Texas, 76104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50 g of carbohydrate drink 2 hours before surgery
650mg acetaminophen 30 minutes prior to surgery
Other names: tylenol
300 mg gabapentin 30 minutes prior to surgery
Other names: Neurontin, Gralise
intraoperative local anesthetic
Other names: Marcaine, Sensorcaine
Assisted ambulation 12 hours after surgery
Time frame: From enrollment to the end of treatment at 30 days
Patient reported pain on a scale from 0 (no pain) to 10 (the worst possible pain)
Time frame: From enrollment to the end of treatment at 30 days
milligram morphine equivalents (MME)
Time frame: From enrollment to the end of treatment at 30 days
unfavorable medical occurence
Time frame: From enrollment to the end of treatment at 30 days
readmission to any hospital within 30 days
Time frame: From enrollment to the end of treatment at 30 days
total hospital length of stay
Baylor Research Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723352
Joint Replacement, Joint Replacement Surgery
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07568405
Intravenous Anesthesia, Neurologic Manifestations
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT07527065
Neurologic Manifestations, Pain
Çorum, Turkey (Türkiye)
View Trial DetailsNCT07311889
Neurologic Manifestations, Pain
Irvine, California, United States
View Trial Details